Results 181 to 190 of about 840,950 (218)

Beta-Thalassemia Syndromes and Pregnancy

Obstetrical & Gynecological Survey, 1994
The literature relating to homozygous beta-thalassemia and the problems these patients have during their pregnancy is reviewed and another case report of a twin pregnancy in a homozygous beta-thalassemia individual is included. The majority of cases described refer to the intermedia clinical form of the hematological problem because patients with ...
C, Savona-Ventura, F, Bonello
openaire   +2 more sources

Neurological complications of beta-thalassemia

Annals of Hematology, 2015
The thalassemias are the most common single gene disorder in the world. Over the last years, several reports have demonstrated neurological complications in beta-thalassemia patients. In most cases, these complications remained subclinical and were detected only during neuropsychological, neurophysiological, or neuroimaging evaluation.
P. Nemtsas, M. Arnaoutoglou, V. Perifanis, E. Koutsouraki, A. Orologas   +4 more
openaire   +2 more sources

The Silent Carrier of Beta Thalassemia

New England Journal of Medicine, 1969
Abstract A family of Albanian descent had an unusual form of beta thalassemia. The father of two children with mild thalassemia major had normal red-cell morphology and normal levels of hemoglobins A2 and F, whereas the mother had elevated hemoglobin A2.
openaire   +2 more sources

Platyspondyly in treated beta-thalassemia

European Journal of Radiology, 1994
Flattening of the vertebral bodies with a platyspondyly appearance is described in 14 patients selected for evaluation of short stature from 106 patients affected by thalassemia major, who received an intensive transfusion regimen combined with continuous chelation therapy.
C, Orzincolo, G, Castaldi, P N, Scutellari   +2 more
openaire   +2 more sources

[Beta-thalassemia in Germany. Results of cooperative beta-thalassemia study].

Klinische Padiatrie, 2000
At present, about 300 patients with thalassemia major are living in Germany. Starting in 1991, a multicenter study in Germany has concentrated on identifying all patients suffering from thalassemia as well as on establishing a uniform therapy protocol including follow-up diagnostic procedures.
H, Cario, K, Stahnke, E, Kohne
openaire   +1 more source

Cardiac involvement in beta-thalassemia major and beta-thalassemia intermedia.

Hemoglobin, 2005
The forms and severity of cardiac complications were investigated in patients with asymptomatic thalassemia intermedia and thalassemia major by M-mode, bi-dimensional echocardiography (ECHO) and echo-Doppler. Twenty-eight patients of both sexes with beta-thalassemia intermedia (beta-TI), mean age 23.2 +/- 6.3 years, untransfused or minimally transfused,
Mara, Ferrara, Sofia M R, Matarese, Barbara, Borrelli, Angelo, Perrotta, Gelsomina, Simeone, Natalizia, Greco, Diana, Iarussi, Luigi, Esposito   +7 more
openaire   +1 more source

Beta‐Thalassemias

2004
Antonio Cao, Renzo Galanello
openaire   +2 more sources

In Brief: Casgevy for Beta Thalassemia

The Medical Letter on Drugs and Therapeutics
Exagamglogene autotemcel (Casgevy – Vertex), a cell-based gene therapy recently approved for treatment of sickle cell disease1, has now been approved by the FDA for treatment of patients ≥12 years old with transfusion-dependent beta thalassemia.
openaire   +2 more sources

Beta Thalassemia

2022
openaire   +1 more source

Characterization and comparison of the red blood cell membrane damage in severe human alpha- and beta-thalassemia Free

Blood, 1992
Sl Schrier, R Advani, E Shinar
exaly